Disproportionality Analysis and Causal Inference in Drug Safety
Pharmaceutical Medicine · 2025-03 · 39 (2) · 97-107
DOI: 10.1007/s40290-024-00549-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutical Medicine, online erschienen am 04.03.2025. Verfasst von Emil Scosyrev und 4 weiteren Autor:innen. Beteiligte Einrichtung: Quantitative Safety and Epidemiology, Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936-1080, USA. emil.scosyrev@novart…. Hauptthemen laut MEDLINE: Drug-Related Side Effects and Adverse Reactions, Adverse Drug Reaction Reporting Systems. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Quantitative Safety and Epidemiology, Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936-1080, USA. emil.scosyrev@novartis.com.
- Novartis Pharma AG, Basel, Switzerland.
- Novartis Healthcare Pvt Ltd, Hyderabad, India.
ORCID-Profile: Emil Scosyrev
Zitieren
APA
Scosyrev, E., Behr, S., Jain, D., Ponnuru, A., & Michel, C. (2025). Disproportionality Analysis and Causal Inference in Drug Safety. Pharmaceutical Medicine, 39(2), 97-107. https://doi.org/10.1007/s40290-024-00549-4
Vancouver
Scosyrev E, Behr S, Jain D, Ponnuru A, Michel C. Disproportionality Analysis and Causal Inference in Drug Safety. Pharmaceutical Medicine. 2025;39(2):97-107. doi:10.1007/s40290-024-00549-4
BibTeX
@article{Scosyrev2025,
author = {Scosyrev, Emil and Behr, Sigrid and Jain, Devendra and Ponnuru, Arun and Michel, Christiane},
title = {Disproportionality Analysis and Causal Inference in Drug Safety},
journal = {Pharmaceutical Medicine},
year = {2025},
volume = {39},
number = {2},
pages = {97--107},
doi = {10.1007/s40290-024-00549-4}
}
EUVIMED